N/A
Completed N=226
Intervention Trial to Reduce Mental Health Disparities in Latina Immigrant Women
Source: ClinicalTrials.gov NCT03545282 ↗Enrolled (actual)
226
Serious AEs
0.0%
Results posted
May 2024
Primary outcomePrimary: Depressive Symptoms — 7.01; 6.61; 4.96; 6.39 score on a scale
Summary
Latina immigrant women are particularly vulnerable to depression and anxiety due to the social and economic stressors they face, including high levels of poverty, low levels of education, family obligations, exposure to violence, and limited access to community resources. ALMA aims to prevent and reduce depression and anxiety among Latina immigrant women. Women attend 8 weekly sessions in a group format to teach and encourage women to use coping strategies to reduce depression and anxiety. The intervention aims to increase participants' social ties and the social support they receive from other Latina immigrant women. The program also helps decrease the stigma associated with mental health and connects women to mental health services when needed.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Depressive Symptoms |
7.01; 6.61; 4.96; 6.39; 5.19; 6.31 | — |
| PRIMARY Anxiety Symptoms |
6.71; 7.02; 4.09; 5.56; 4.30; 5.35 | — |
| SECONDARY Stress |
6.36; 6.27; 5.20; 5.65; 5.19; 5.73 | — |
Eligibility Criteria
Inclusion Criteria
- To be eligible for study participation, participants must be at least 18 years of age, female, speak Spanish, must self-identify as Latina, and have been born outside of the United States.
Exclusion Criteria
- Participant screened for high levels of depressive symptoms (as indicated by a score of 20 or higher on the PHQ-9) which indicates severe symptoms. Participants with scores above 20 were referred to the licensed mental health counselor on the study team. If these women are not already receiving mental health treatment, they will be referred to mental health providers offering low-cost services in Spanish. The counselor will discuss participation in the program with the potential participants and make the final determination about their ability to participate based on the care they are currently receiving and the severity of their symptoms.
Data sourced from ClinicalTrials.gov (NCT03545282). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.